All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0722-LX344 | Anti-FOLH1 (X7X136) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X136 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX345 | Anti-FOLH1 (X7X137) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X137 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX346 | Anti-FOLH1 (X7X138) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X138 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX347 | Anti-FOLH1 (X7X139) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X139 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX348 | Anti-FOLH1 (X7X140) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X140 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX349 | Anti-FOLH1 (X7X141) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X141 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX350 | Anti-FOLH1 (X7X142) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X142 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX351 | Anti-FOLH1 (X7X143) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | human | X7X143 | human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX535 | Anti-FOLH1 (X7X119) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | human | X7X119 | Humanized | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX536 | Anti-FOLH1 (X7X120) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | human | X7X120 | Humanized | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX537 | Anti-FOLH1 (X7X121) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | human | X7X121 | Humanized | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-LX721 | Anti-FOLH1 (X7X97) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X97 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX722 | Anti-FOLH1 (X7X98) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X98 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX723 | Anti-FOLH1 (X7X99) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X99 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX724 | Anti-FOLH1 (X7X100) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X100 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX725 | Anti-FOLH1 (X7X101) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X101 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX726 | Anti-FOLH1 (X7X102) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X102 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX773 | Anti-FOLH1 (X7X149) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X149 | mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX774 | Anti-FOLH1 (X7X150) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X150 | mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0722-LX775 | Anti-FOLH1 (X7X151) h(CD28-41BB-CD3ζ) CAR, pMMLV | human | X7X151 | mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION